Stay updated on Prevent Early Onset AD Clinical Trial
Sign up to get notified when there's something new on the Prevent Early Onset AD Clinical Trial page.

Latest updates to the Prevent Early Onset AD Clinical Trial page
- Check4 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0; the study record still displays a 403 Forbidden page.SummaryDifference0.2%

- Check11 days agoChange DetectedA banner announces NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” and links to transition updates and FAQs.SummaryDifference1%

- Check18 days agoChange DetectedThe footer revision identifier advances from v3.7.1 to v3.7.2, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedThe site footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check39 days agoChange DetectedThe page now displays a 403 Forbidden error with the site chrome and a Home link, indicating restricted access to the study record. This reflects an access restriction rather than a substantive update to the study content.SummaryDifference0.5%

- Check46 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the usual study content; the screenshot shows minimal navigation (Home) and a revision stamp, indicating an access issue rather than the full trial record.SummaryDifference21%

Stay in the know with updates to Prevent Early Onset AD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Prevent Early Onset AD Clinical Trial page.